Elon Musk's brain implant company Neuralink says it has US approval to begin trials in people

  • 📰 ksatnews
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

Elon Musk’s brain implant company Neuralink says it's gotten permission from U.S. regulators to begin testing its device in people.

Musk – who also owns Twitter and is the CEO of Tesla and SpaceX – said last December that his team was in the process of asking regulators to allow them to test the Neuralink device.

After Musk made a presentation late last year about the device, Rajesh Rao, co-director of the Center for Neurotechnology at the University of Washington, said he doesn’t think Neuralink is ahead of other teams in terms of brain-computer interface achievements but is “quite ahead” in terms of the hardware in the devices.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 442. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Elon Musk’s brain chip company Neuralink gets FDA approval: What to knowNeuralink said it has regulatory approval to conduct a clinical trial of its brain implants in people, a milestone for the company as it seeks to commercialize a device that will link human brains to computers.
La source: washingtonpost - 🏆 95. / 72 Lire la suite »

Elon Musk's Brain Implant Company Neuralink Announces FDA Approval of In-Human Clinical StudyNeuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.
La source: nbcbayarea - 🏆 596. / 51 Lire la suite »